Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Under valuation model assumptions realized through 12/31/28, the stock is modeled using: Revenue growth (CAGR): 15.9% Operating Margins: 4.5% Exit P/E Multiple: 24.7x Based on these inputs, the model estimates a target price of $33, implying 17.7% total upside from the current share price of $28 and a 6.3% annualized return over the next 2.7 years
This preparation ensures medication readiness from day one
It is not approved by the FDA
When to Discard Your Vial Knowing when to throw out a vial is just as important as knowing how to reconstitute one
US$ 28.22
US$ 28.46
US$ 27.30
US$ 25.26
US$ 23.78
